Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DIURNAL LIMITED

Home Clinical Trial Sponsors and OrganizationsDIURNAL LIMITED

DIURNAL LIMITED

THE CARDIFF MEDICENTRE, Cardiff, United Kingdom

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

24

5 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

15

62.5%

Phase 3

6

25.0%

Phase 2

2

8.3%

Trial Status Distribution

Active, not recruiting

5

20.8%

Completed

18

75.0%

Withdrawn

1

4.2%

Clinical Trials

Trials sponsored by this organization (24)

Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia

May 202255 participants

Double-blind comparison of Chronocort versus standard hydrocortisone replacement therapy in participants aged 16 years and over with congenital adrenal hyperplasia

May 202215 participants

An Open-label Extension Study to Evaluate the Long-term Safety andTolerability of Chronocort in the Treatment of Participants Aged 16 Years and Over with Congenital Adrenal Hyperplasia

Active, not recruiting

Dec 2021181 participants

Double-blind comparison of Chronocort versus standard hydrocortisone replacement therapy in participants aged 16 years and over with congenital adrenal hyperplasia

Active, not recruiting

Dec 2021150 participants

Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency

Nov 202158 participants

Chronocort versus Plenadren replacement therapy in adults with adrenal insufficiency

Active, not recruiting

Aug 202150 participants

Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy

A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects

Apr 201851 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials24
Approvals
News

Back to Organizations